Journal article Open Access

Early decrease of type 1 cannabinoid receptor binding and phosphodiesterase 10A activity in vivo in R6/2 Huntington mice.

Ooms, Maarten; Rietjens, Roma; Rangarajan, Janaki Raman; Vunckx, Kathleen; Valdeolivas, Sara; Maes, Frederik; Himmelreich, Uwe; Fernandez-Ruiz, Javier; Bormans, Guy; Van Laere, Koen; Casteels, Cindy


DCAT Export

<?xml version='1.0' encoding='utf-8'?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:adms="http://www.w3.org/ns/adms#" xmlns:cnt="http://www.w3.org/2011/content#" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dct="http://purl.org/dc/terms/" xmlns:dctype="http://purl.org/dc/dcmitype/" xmlns:dcat="http://www.w3.org/ns/dcat#" xmlns:duv="http://www.w3.org/ns/duv#" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:frapo="http://purl.org/cerif/frapo/" xmlns:geo="http://www.w3.org/2003/01/geo/wgs84_pos#" xmlns:gsp="http://www.opengis.net/ont/geosparql#" xmlns:locn="http://www.w3.org/ns/locn#" xmlns:org="http://www.w3.org/ns/org#" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:prov="http://www.w3.org/ns/prov#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:schema="http://schema.org/" xmlns:skos="http://www.w3.org/2004/02/skos/core#" xmlns:vcard="http://www.w3.org/2006/vcard/ns#" xmlns:wdrs="http://www.w3.org/2007/05/powder-s#">
  <rdf:Description rdf:about="https://zenodo.org/record/16298">
    <rdf:type rdf:resource="http://www.w3.org/ns/dcat#Dataset"/>
    <dct:type rdf:resource="http://purl.org/dc/dcmitype/Text"/>
    <dct:identifier rdf:datatype="http://www.w3.org/2001/XMLSchema#anyURI">https://zenodo.org/record/16298</dct:identifier>
    <foaf:page rdf:resource="https://zenodo.org/record/16298"/>
    <dct:creator>
      <rdf:Description>
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Agent"/>
        <foaf:name>Ooms, Maarten</foaf:name>
        <foaf:givenName>Maarten</foaf:givenName>
        <foaf:familyName>Ooms</foaf:familyName>
        <org:memberOf>
          <foaf:Organization>
            <foaf:name>Laboratory for Radiopharmacy, KU Leuven, Belgium and MoSAIC, Molecular Small Animal Imaging Centre, KU Leuven, Belgium</foaf:name>
          </foaf:Organization>
        </org:memberOf>
      </rdf:Description>
    </dct:creator>
    <dct:creator>
      <rdf:Description>
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Agent"/>
        <foaf:name>Rietjens, Roma</foaf:name>
        <foaf:givenName>Roma</foaf:givenName>
        <foaf:familyName>Rietjens</foaf:familyName>
        <org:memberOf>
          <foaf:Organization>
            <foaf:name>MoSAIC, Molecular Small Animal Imaging Centre, KU Leuven, Belgium and Division of Nuclear Medicine, KU Leuven and University Hospital Leuven, Belgium</foaf:name>
          </foaf:Organization>
        </org:memberOf>
      </rdf:Description>
    </dct:creator>
    <dct:creator>
      <rdf:Description>
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Agent"/>
        <foaf:name>Rangarajan, Janaki Raman</foaf:name>
        <foaf:givenName>Janaki Raman</foaf:givenName>
        <foaf:familyName>Rangarajan</foaf:familyName>
        <org:memberOf>
          <foaf:Organization>
            <foaf:name>KU Leuven Medical Image Computing (ESAT/PSI), Department of Electrical Engineering &amp; Medical Imaging Research Center, University Hospital Leuven, Belgium</foaf:name>
          </foaf:Organization>
        </org:memberOf>
      </rdf:Description>
    </dct:creator>
    <dct:creator>
      <rdf:Description>
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Agent"/>
        <foaf:name>Vunckx, Kathleen</foaf:name>
        <foaf:givenName>Kathleen</foaf:givenName>
        <foaf:familyName>Vunckx</foaf:familyName>
        <org:memberOf>
          <foaf:Organization>
            <foaf:name>Division of Nuclear Medicine, KU Leuven and University Hospital Leuven, Belgium</foaf:name>
          </foaf:Organization>
        </org:memberOf>
      </rdf:Description>
    </dct:creator>
    <dct:creator>
      <rdf:Description>
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Agent"/>
        <foaf:name>Valdeolivas, Sara</foaf:name>
        <foaf:givenName>Sara</foaf:givenName>
        <foaf:familyName>Valdeolivas</foaf:familyName>
        <org:memberOf>
          <foaf:Organization>
            <foaf:name>Departamento de Bioquímica y Biología Molecular, Facultad de Medicina, Universidad Complutense, Madrid, Spain; Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Spain and Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain</foaf:name>
          </foaf:Organization>
        </org:memberOf>
      </rdf:Description>
    </dct:creator>
    <dct:creator>
      <rdf:Description>
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Agent"/>
        <foaf:name>Maes, Frederik</foaf:name>
        <foaf:givenName>Frederik</foaf:givenName>
        <foaf:familyName>Maes</foaf:familyName>
        <org:memberOf>
          <foaf:Organization>
            <foaf:name>KU Leuven Medical Image Computing (ESAT/PSI), Department of Electrical Engineering &amp; Medical Imaging Research Center, University Hospital Leuven, Belgium</foaf:name>
          </foaf:Organization>
        </org:memberOf>
      </rdf:Description>
    </dct:creator>
    <dct:creator>
      <rdf:Description>
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Agent"/>
        <foaf:name>Himmelreich, Uwe</foaf:name>
        <foaf:givenName>Uwe</foaf:givenName>
        <foaf:familyName>Himmelreich</foaf:familyName>
        <org:memberOf>
          <foaf:Organization>
            <foaf:name>Biomedical NMR Unit, KU Leuven, Belgium</foaf:name>
          </foaf:Organization>
        </org:memberOf>
      </rdf:Description>
    </dct:creator>
    <dct:creator>
      <rdf:Description>
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Agent"/>
        <foaf:name>Fernandez-Ruiz, Javier</foaf:name>
        <foaf:givenName>Javier</foaf:givenName>
        <foaf:familyName>Fernandez-Ruiz</foaf:familyName>
        <org:memberOf>
          <foaf:Organization>
            <foaf:name>Departamento de Bioquímica y Biología Molecular, Facultad de Medicina, Universidad Complutense, Madrid, Spain; Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Spain and Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain</foaf:name>
          </foaf:Organization>
        </org:memberOf>
      </rdf:Description>
    </dct:creator>
    <dct:creator>
      <rdf:Description>
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Agent"/>
        <foaf:name>Bormans, Guy</foaf:name>
        <foaf:givenName>Guy</foaf:givenName>
        <foaf:familyName>Bormans</foaf:familyName>
        <org:memberOf>
          <foaf:Organization>
            <foaf:name>Laboratory for Radiopharmacy, KU Leuven, Belgium and MoSAIC, Molecular Small Animal Imaging Centre, KU Leuven, Belgium</foaf:name>
          </foaf:Organization>
        </org:memberOf>
      </rdf:Description>
    </dct:creator>
    <dct:creator>
      <rdf:Description>
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Agent"/>
        <foaf:name>Van Laere, Koen</foaf:name>
        <foaf:givenName>Koen</foaf:givenName>
        <foaf:familyName>Van Laere</foaf:familyName>
        <org:memberOf>
          <foaf:Organization>
            <foaf:name>MoSAIC, Molecular Small Animal Imaging Centre, KU Leuven, Belgium and Division of Nuclear Medicine, KU Leuven and University Hospital Leuven, Belgium</foaf:name>
          </foaf:Organization>
        </org:memberOf>
      </rdf:Description>
    </dct:creator>
    <dct:creator>
      <rdf:Description>
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Agent"/>
        <foaf:name>Casteels, Cindy</foaf:name>
        <foaf:givenName>Cindy</foaf:givenName>
        <foaf:familyName>Casteels</foaf:familyName>
        <org:memberOf>
          <foaf:Organization>
            <foaf:name>MoSAIC, Molecular Small Animal Imaging Centre, KU Leuven, Belgium and Division of Nuclear Medicine, KU Leuven and University Hospital Leuven, Belgium</foaf:name>
          </foaf:Organization>
        </org:memberOf>
      </rdf:Description>
    </dct:creator>
    <dct:title>Early decrease of type 1 cannabinoid receptor binding and phosphodiesterase 10A activity in vivo in R6/2 Huntington mice.</dct:title>
    <dct:publisher>
      <foaf:Agent>
        <foaf:name>Zenodo</foaf:name>
      </foaf:Agent>
    </dct:publisher>
    <dct:issued rdf:datatype="http://www.w3.org/2001/XMLSchema#gYear">2014</dct:issued>
    <dcat:keyword>Type 1 cannabinoid receptor, ,, ,</dcat:keyword>
    <dcat:keyword>phosphodiesterase 10A</dcat:keyword>
    <dcat:keyword>Huntington disease</dcat:keyword>
    <dcat:keyword>small-animal PET</dcat:keyword>
    <dcat:keyword>R6/2 mice</dcat:keyword>
    <frapo:isFundedBy rdf:resource="info:eu-repo/grantAgreement/EC/FP7/278850/"/>
    <schema:funder>
      <foaf:Organization>
        <dct:identifier rdf:datatype="http://www.w3.org/2001/XMLSchema#string">10.13039/501100000780</dct:identifier>
        <foaf:name>European Commission</foaf:name>
      </foaf:Organization>
    </schema:funder>
    <dct:issued rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2014-06-16</dct:issued>
    <owl:sameAs rdf:resource="https://zenodo.org/record/16298"/>
    <adms:identifier>
      <adms:Identifier>
        <skos:notation rdf:datatype="http://www.w3.org/2001/XMLSchema#anyURI">https://zenodo.org/record/16298</skos:notation>
      </adms:Identifier>
    </adms:identifier>
    <owl:sameAs rdf:resource="https://doi.org/10.1016/j.neurobiolaging.2014.06.010"/>
    <dct:isPartOf rdf:resource="https://zenodo.org/communities/inmind"/>
    <dct:isPartOf rdf:resource="https://zenodo.org/communities/ecfunded"/>
    <dct:description>&lt;p&gt;Purpose: Several lines of evidence imply early alterations in endocannabinoid and phosphodiesterase&amp;nbsp;10A (PDE10A) signaling in Huntington disease (HD). Using [18F]MK-9470 and [18F]JNJ42259152&amp;nbsp;small-animal PET, we investigated for the first time cerebral changes in type 1 cannabinoid (CB1)&amp;nbsp;receptor binding and PDE10A levels in vivo in pre-, early- and late symptomatic HD (R6/2) mice, in&amp;nbsp;relation to glucose metabolism ([18F]FDG PET), brain morphology (MRI) and motor function.&amp;nbsp;&lt;/p&gt; &lt;p&gt;Methods:&amp;nbsp;Ten R6/2 and 16 wild-type (WT) mice were investigated at 3 different time points between the age of 4&amp;nbsp;and 13 weeks. Parametric CB1 receptor and PDE10A images were anatomically standardized to&amp;nbsp;Paxinos space and analyzed voxel-wise. Volumetric microMRI imaging was performed to assess HD&amp;nbsp;pathology.&amp;nbsp;&lt;/p&gt; &lt;p&gt;Results: In R6/2 mice, CB1 receptor binding was decreased in comparison to WT in a&amp;nbsp;cluster comprising the bilateral caudate-putamen, globus pallidus and thalamic nucleus at week 5 (-8.1&amp;plusmn;2.6%; p=1.7.10-5). Longitudinal follow-up showed further progressive decline compared to controls&amp;nbsp;in a cluster comprising the bilateral hippocampus, caudate-putamen, globus pallidus, superior&amp;nbsp;colliculus, thalamic nucleus and cerebellum (late vs. presymptomatic age: -13.7&amp;plusmn;3.1% for R6/2 and&amp;nbsp;+1.5&amp;plusmn;4.0% for WT; p=1.9.10-5). In R6/2 mice, PDE10A binding potential also decreased over time, to&amp;nbsp;reach significance at early and late symptomatic HD (late vs. presymptomatic age: -79.1&amp;plusmn;1.9% for&amp;nbsp;R6/2 and +2.1&amp;plusmn;2.7% for WT; p=1.5.10-4). The observed changes in CB1 receptor and PDE10A binding&amp;nbsp;were correlated to anomalies exhibited by R6/2 animals in motor function, while no correlation was&amp;nbsp;found with MRI-based striatal volume.&amp;nbsp;&lt;/p&gt; &lt;p&gt;Conclusion: Our findings point to early regional dysfunctions in&amp;nbsp;endocannabinoid and PDE10A signaling, involving the caudate-putamen and lateral globus pallidus,&amp;nbsp;that may play a role in the progression of the disease in R6/2 animals. PET quantification of in vivo&amp;nbsp;CB1 and/or PDE10A binding may thus be useful early biomarkers for HD. Our results also provide&amp;nbsp;evidence of subtle motor deficits at earlier stages than previously described.&lt;/p&gt;</dct:description>
    <dct:accessRights rdf:resource="http://publications.europa.eu/resource/authority/access-right/PUBLIC"/>
    <dct:accessRights>
      <dct:RightsStatement rdf:about="info:eu-repo/semantics/openAccess">
        <rdfs:label>Open Access</rdfs:label>
      </dct:RightsStatement>
    </dct:accessRights>
    <dcat:distribution>
      <dcat:Distribution>
        <dct:license rdf:resource="http://creativecommons.org/publicdomain/zero/1.0/legalcode"/>
        <dcat:accessURL rdf:resource="https://zenodo.org/record/16298"/>
      </dcat:Distribution>
    </dcat:distribution>
  </rdf:Description>
  <foaf:Project rdf:about="info:eu-repo/grantAgreement/EC/FP7/278850/">
    <dct:identifier rdf:datatype="http://www.w3.org/2001/XMLSchema#string">278850</dct:identifier>
    <dct:title>Imaging of Neuroinflammation in Neurodegenerative Diseases</dct:title>
    <frapo:isAwardedBy>
      <foaf:Organization>
        <dct:identifier rdf:datatype="http://www.w3.org/2001/XMLSchema#string">10.13039/501100000780</dct:identifier>
        <foaf:name>European Commission</foaf:name>
      </foaf:Organization>
    </frapo:isAwardedBy>
  </foaf:Project>
</rdf:RDF>
44
61
views
downloads
Views 44
Downloads 61
Data volume 334.9 MB
Unique views 44
Unique downloads 61

Share

Cite as